Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)

Abstract

Background: Patients with wake-up ischemic stroke are frequently excluded from thrombolytic treatment due to unknown symptom onset time and limited availability of advanced imaging modalities. The Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST) is a randomized controlled trial of intravenous tenecteplase 0.25 mg/kg and standard care versus standard care alone (no thrombolysis) in patients who wake up with acute ischemic stroke and can be treated within 4.5 h of wakening based on non-contrast CT findings.<p> <p>Objective: To publish the detailed statistical analysis plan for TWIST prior to unblinding. Methods: The TWIST statistical analysis plan is consistent with the Consolidating Standard of Reporting Trials (CON‑ SORT) statement and provides clear and open reporting. <p>Discussion: Publication of the statistical analysis plan serves to reduce potential trial reporting bias and clearly out‑ lines the pre-specifed analyses. <p>Trial registration: ClinicalTrials.gov NCT03181360. EudraCT Number 2014-000096-80. WHO ICRTP registry number ISRCTN10601890.